Key result
Pioglitazone normalizes LV dimensions and ameliorates endothelial-myocyte uncoupling in diabetic mice.
Why the study?
PPARgamma agonists may ameliorate cardiovascular complications in diabetes mellitus, but mechanisms involving MMP-9 activation and LV homocysteine levels in diabetic cardiac remodeling are unclear.
Does pioglitazone prevent cardiac remodeling in a high-fat, high-calorie-induced Type 2 diabetes mellitus mouse model?
Does pioglitazone prevent cardiac remodeling in a high-fat, high-calorie-induced Type 2 diabetes mellitus mouse model?
Pioglitazone prevents cardiac remodeling and endothelial-myocyte uncoupling in a mouse model of diet-induced Type 2 diabetes, associated with normalized LV homocysteine and decreased MMP activities.
May attenuate diabetic cardiomyopathy via MMP-9/Hcy in mice; leaves open human translation.
The agonists of peroxisome proliferator-activated receptor-gamma (PPARgamma) ameliorate cardiovascular complications associated with diabetes mellitus. We tested the hypothesis that recovery from ailing to failing myocardium in diabetes by PPARgamma agonist is in part due to decreased matrix metalloproteinase-9 (MMP-9) activation and left ventricular (LV) tissue levels of homocysteine (Hcy). C57BL/6J mice were made diabetic (D) by feeding them a high-fat calorie diet. PPARgamma was activated by adding pioglitazone (Pi) to the diet. After 6 wk, mice were grouped into: normal calorie diet (N), D, N + Pi and D + Pi (n = 6 in each group). LV variables were measured by echocardiography, endothelial-myocyte (E-M) coupling was measured in cardiac rings, and MMP-9 activation was measured by zymography. Blood glucose levels were twofold higher in D mice compared with N mice. Pi decreased the levels of glucose in D mice to the levels in N mice. LV Hcy levels were 3.5 +/- 0.5 microM in N groups compared with 12.4 +/- 0.6 microM in D groups. Treatment with Pi normalized the LV levels of Hcy but had no effect on plasma levels of Hcy. In the D group, LV contraction was reduced compared with that of the N group and was ameliorated by treatment with Pi. LV wall thickness was reduced to 0.25 +/- 0.02 mm in the D group compared with 0.42 +/- 0.01 mm in the N group. LV diastolic diameter was 3.05 +/- 0.01 mm in the D group compared with 2.20 +/- 0.02 mm in the N group. LV systolic diameter was 1.19 +/- 0.02 mm in the D group and 0.59 +/- 0.01 mm in the N group. Pi normalized the LV variables in D mice. The responses to ACh and nitroprusside were attenuated in diabetic hearts, suggesting that there was E-M uncoupling in the D group compared with the N group, which was ameliorated by Pi. Plasma and LV levels of MMP-2 and -9 activities were higher in the D group than in the N group but normalized after Pi treatment. These results suggest that E-M uncoupling in the myocardium, in part, is due to increased MMP activities secondary to suppressing PPARgamma activity in high-fat, calorie-induced Type 2 diabetes mellitus.
No takes yet. Share an insight, caveat, or question.
Rodríguez et al. (2006) studied Type 2 diabetes mellitus (n=24). Pioglitazone vs. Normal calorie diet and diabetic without pioglitazone was evaluated on Left ventricular variables, endothelial-myocyte coupling, and MMP-9 activation. Pioglitazone normalized left ventricular homocysteine levels, wall thickness, and diameters, and ameliorated endothelial-myocyte uncoupling in mice with high-fat diet-induced Type 2 diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: